Why Every Pharmaceutical Company Needs Better Clinical Trial Intelligence

The pharmaceutical industry is spending over $300 billion annually on R&D. Timelines are lengthening. Margins are narrowing. And 80 to 85% of clinical trials are still missing enrollment targets — at a cost of $800,000 for every day they run behind.
More Info: https://clival.com/blog/why ...